Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus
about
Talaromyces (Penicillium) marneffei infection in non-HIV-infected patientsAntilymphocyte antibodies in systemic lupus erythematosus: association with disease activity and lymphopeniaEuropean League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies[Frequency, clinical implication and prognostic value of lymphopenia in systemic lupus erythematosus: case-control study]Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency.Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupusThe halo sign: HRCT findings in 85 patients.Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.Severe infections in patients with lupus nephritis treated with immunosuppressants: A retrospective cohort study.Clinical and immunological manifestations in 151 SLE patients living in Dubai.Lymphocytopenia may be a new indicator for infected obstructed kidneys secondary to urinary stone disease.Incidence and risk of infection in egyptian patients with systemic lupus erythematosus.Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice.Herpes zoster in patients with systemic lupus erythematosus: Clinical features, complications and risk factors.The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.Incidence rate and causes of infection in Thai systemic sclerosis patients.Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.Immunological and Clinical Characteristics of Systemic Lupus Erythematosus: A Series from Morocco
P2860
Q26767153-BBBDE082-6E09-4990-B788-5F087665DF33Q33594070-2D52305A-7F70-4C6F-B1E6-D7F5FA2E0127Q34187282-B570BA40-9835-4543-988F-D83F6B782E99Q36031383-03D36C2C-3378-4A88-884D-A1361CB8DE02Q36237328-1D614E04-87DB-407B-BFBC-DE19718AD949Q36800112-2E718846-DB26-4BF8-A682-A0E10DC03A62Q37691258-A99A822C-97A8-45F6-8468-9DB1837B50D3Q38798798-8B4D3F61-AECC-4C88-BAB6-95E26068DC41Q39792182-C852226D-70CD-4184-A36E-CDFECD39C549Q39826202-4D267F96-BED6-4F30-AC23-9D0FA8C17156Q40182720-F3A094EB-FD48-4C0F-BB01-E01ECB8F8EBBQ42199801-A020507E-AB8D-4867-893C-D0D6DAC0BA02Q45185130-7DAE08C6-C5CB-4507-8B16-911194D51BFFQ47138126-B83E3FE5-2DC1-4AAC-92FC-9860C427B026Q47139465-8F8B6027-212A-4052-B9E4-FFC16DB5F110Q47981156-8FFB5F61-2AB6-40CF-9F23-884A576BD237Q51331191-80AE5C84-59A6-4158-9704-A0A08CC3E3A8Q53568077-3518770D-CD6C-4597-A894-3CAC92FF4551Q58603868-C18CE2FB-FCAB-49A7-9698-D5A8AABE4CE9
P2860
Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@ast
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@en
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@nl
type
label
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@ast
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@en
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@nl
prefLabel
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@ast
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@en
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@nl
P2093
P2860
P356
P1476
Lymphopenia at presentation is ...... h systemic lupus erythematosus
@en
P2093
P2860
P356
10.1093/QJMED/HCI155
P407
P577
2006-01-01T00:00:00Z